8-K: Cardio Diagnostics Granted Second Extension to Regain Nasdaq Compliance

Cardio Diagnostics Holdings, Inc. has received a second extension from Nasdaq to regain compliance with the minimum bid price requirement, now until June 2, 2025.

Summary

• Cardio Diagnostics Holdings, Inc. received a notice from Nasdaq on June 3, 2024, stating they were not compliant with the minimum bid price requirement of $1.00 per share.
• The company was initially given 180 days, until December 2, 2024, to regain compliance.
• As of December 4, 2024, the company had not regained compliance.
• Nasdaq has granted the company a second 180-day extension, until June 2, 2025, to regain compliance.
• This extension is based on the company meeting other listing requirements and its intention to cure the deficiency, potentially through a reverse stock split.
• The company must complete any reverse stock split at least ten business days before the end of the second compliance period.
• If the company does not regain compliance by June 2, 2025, it could face delisting from Nasdaq.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the company's continued non-compliance with Nasdaq listing rules and the potential for delisting. The second extension provides some relief, but the underlying issue of a low stock price remains a significant concern.

Positives

• The company has been granted a second extension to regain compliance, providing more time to address the issue.
• Nasdaq has acknowledged that the company meets all other listing requirements except for the minimum bid price.
• The company has indicated its intention to cure the deficiency, including considering a reverse stock split.

Negatives

• The company's stock price has remained below the required $1.00 minimum bid price.
• The company is at risk of being delisted from Nasdaq if it does not regain compliance by June 2, 2025.
• The company may need to implement a reverse stock split, which can negatively impact shareholder value.

Risks

• The company may not be able to regain compliance with the minimum bid price requirement by the June 2, 2025 deadline.
• A reverse stock split may be necessary, which could negatively impact the stock price.
• There is no guarantee that the company will be able to avoid delisting from Nasdaq.
• The company's stock price may continue to decline if it does not regain compliance.

Future Outlook

The company intends to cure the deficiency and will consider all available options, including a reverse stock split, to regain compliance with the minimum bid price requirement. However, there is no assurance that the company will be able to avoid delisting.

Management Comments

• The company intends to cure the deficiency between now and the expiration of the Second Compliance Period.
• The company will consider all available options to resolve the deficiency including effecting a reverse stock split.
• The company has every intention to regain compliance with the Minimum Bid Price Requirement.

Industry Context

This announcement is not uncommon for companies that have experienced a decline in their stock price. Many companies face similar challenges in maintaining compliance with exchange listing requirements.

Comparison to Industry Standards

• Many companies listed on the Nasdaq Capital Market have faced similar challenges with maintaining the minimum bid price.
• Reverse stock splits are a common strategy used by companies to regain compliance with listing requirements.
• The 180-day extension period is a standard procedure for companies that fail to meet the minimum bid price requirement.

Stakeholder Impact

• Shareholders face the risk of further stock price decline and potential delisting.
• Employees may be concerned about the company's future prospects.
• Customers and suppliers may be impacted by the uncertainty surrounding the company's listing status.

Next Steps

• The company will consider options to regain compliance, including a reverse stock split.
• The company must regain compliance by June 2, 2025, to avoid delisting.
• The company may appeal a delisting decision to the Nasdaq Hearings Panel if necessary.

Key Dates

Keywords

Nasdaq, minimum bid price, compliance, delisting, reverse stock split, CDIO, CDIOW